Variants in the LDLR promoter prevent Sp1 transcription factor binding in familial hypercholesterolemia, lowering the expression of the LDL receptor and increasing plasma LDL cholesterol levels. This evidence concerns the gene LDLR and familial hypercholesterolemia.